{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T15:56:55Z","timestamp":1789833415301,"version":"4.0.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008990","name":"Science and Technology Department of Zhejiang Province","doi-asserted-by":"publisher","award":["2023C03044"],"award-info":[{"award-number":["2023C03044"]}],"id":[{"id":"10.13039\/501100008990","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012175","name":"Zhejiang Traditional Chinese Medicine Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012175","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.intimp.2025.115066","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T06:30:43Z","timestamp":1751005843000},"page":"115066","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Pachymic acid alleviates secondary lymphedema through the modulation of EETs level and the inhibition of lymphatic fibrosis"],"prefix":"10.1016","volume":"162","author":[{"given":"Xiang","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianzheng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoqi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liquan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuli","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6408-0439","authenticated-orcid":false,"given":"Xiaozhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2025.115066_b1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41467-023-43554-y","article-title":"15-Lipoxygenase promotes resolution of inflammation in lymphedema by controlling Treg cell function through IFN-\u03b2","volume":"15","author":"Zamora","year":"2024","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.intimp.2025.115066_b2","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1089\/wound.2021.0041","article-title":"Current understanding of pathological mechanisms of lymphedema","volume":"11","author":"Sung","year":"2022","journal-title":"Adv. Wound Care"},{"issue":"6","key":"10.1016\/j.intimp.2025.115066_b3","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S1470-2045(13)70076-7","article-title":"Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis","volume":"14","author":"DiSipio","year":"2013","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.intimp.2025.115066_b4","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/jnci\/93.2.96","article-title":"Arm edema in breast cancer patients","volume":"93","author":"Erickson","year":"2001","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.intimp.2025.115066_b5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.trsl.2023.01.005","article-title":"Topical captopril: a promising treatment for secondary lymphedema","volume":"257","author":"Brown","year":"2023","journal-title":"Transl. Res."},{"issue":"6","key":"10.1016\/j.intimp.2025.115066_b6","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.758","article-title":"TGF-\u03b21 mediates pathologic changes of secondary lymphedema by promoting fibrosis and inflammation","volume":"12","author":"Baik","year":"2022","journal-title":"Clin. Transl. Med."},{"issue":"3","key":"10.1016\/j.intimp.2025.115066_b7","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190103","article-title":"Transforming growth factor\u2013\u03b2 in tissue fibrosis","volume":"217","author":"Frangogiannis","year":"2020","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.115066_b8","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12943-022-01569-x","article-title":"Targeting TGF-\u03b2 signal transduction for fibrosis and cancer therapy","volume":"21","author":"Peng","year":"2022","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2025.115066_b9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1006\/jaut.1999.0339","article-title":"The inhibitory effects of transforming growth factor-beta-1 (TGF-\u03b21) in autoimmune diseases","volume":"14","author":"Prud\u2019Homme","year":"2000","journal-title":"J. Autoimmun."},{"issue":"5","key":"10.1016\/j.intimp.2025.115066_b10","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s12276-021-00618-7","article-title":"The arachidonic acid metabolite 11, 12-epoxyeicosatrienoic acid alleviates pulmonary fibrosis","volume":"53","author":"Kim","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.intimp.2025.115066_b11","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1194\/jlr.R800038-JLR200","article-title":"Arachidonic acid cytochrome P450 epoxygenase pathway","volume":"50","author":"Spector","year":"2009","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.intimp.2025.115066_b12","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7265486","article-title":"Epoxyeicosatrienoic acids inhibit the activation of murine fibroblasts by blocking the TGF-\u03b21-Smad2\/3 signaling in a ppAR\u03b3-dependent manner","volume":"2022","author":"Tao","year":"2022","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"3","key":"10.1016\/j.intimp.2025.115066_b13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/etm.2022.11484","article-title":"Pharmacological profiles and therapeutic applications of pachymic acid","volume":"24","author":"Wei","year":"2022","journal-title":"Exp. Ther. Med."},{"issue":"12","key":"10.1016\/j.intimp.2025.115066_b14","doi-asserted-by":"crossref","first-page":"5382","DOI":"10.1002\/tox.23824","article-title":"Pachymic acid ameliorates bleomycin-induced pulmonary fibrosis through inhibiting endoplasmic reticulum stress in rats","volume":"39","author":"Li","year":"2024","journal-title":"Environ. Toxicol."},{"issue":"11","key":"10.1016\/j.intimp.2025.115066_b15","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/bbb\/zbac114","article-title":"Pachymic acid alleviates experimental pancreatic fibrosis through repressing NLRP3 inflammasome activation","volume":"86","author":"Li","year":"2022","journal-title":"Biosci. Biotechnol. Biochem."},{"issue":"1\u20133","key":"10.1016\/j.intimp.2025.115066_b16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejphar.2010.08.021","article-title":"Pachymic acid stimulates glucose uptake through enhanced GLUT4 expression and translocation","volume":"648","author":"Huang","year":"2010","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115066_b17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/etm.2023.12019","article-title":"Pachymic acid modulates sirtuin 6 activity to alleviate lipid metabolism disorders","volume":"26","author":"Pan","year":"2023","journal-title":"Exp. Ther. Med."},{"issue":"5","key":"10.1016\/j.intimp.2025.115066_b18","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/biolre\/ioaa141","article-title":"Pachymic acid protects oocyte by improving the ovarian microenvironment in polycystic ovary syndrome mice","volume":"103","author":"Fu","year":"2020","journal-title":"Biol. Reprod."},{"issue":"3","key":"10.1016\/j.intimp.2025.115066_b19","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1165\/rcmb.2020-0504OC","article-title":"Connective-tissue growth factor contributes to TGF-\u03b21\u2013induced lung fibrosis","volume":"66","author":"Yanagihara","year":"2022","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"key":"10.1016\/j.intimp.2025.115066_b20","first-page":"1","article-title":"Pachymic acid ameliorates pulmonary hypertension by regulating Nrf2-Keap1-ARE pathway","author":"He","year":"2022","journal-title":"Curr. Med. Sci."},{"key":"10.1016\/j.intimp.2025.115066_b21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jare.2021.06.023","article-title":"Activation of Nrf2\/HO-1 signaling: An important molecular mechanism of herbal medicine in the treatment of atherosclerosis via the protection of vascular endothelial cells from oxidative stress","volume":"34","author":"Zhang","year":"2021","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.intimp.2025.115066_b22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114278","article-title":"Systems pharmacological study based on UHPLC-Q-Orbitrap-HRMS, network pharmacology and experimental validation to explore the potential mechanisms of Danggui-Shaoyao-San against atherosclerosis","volume":"278","author":"Bi","year":"2021","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115066_b23","first-page":"3","article-title":"The diagnosis and treatment of peripheral lymphedema: 2020 Consensus Document of the International Society of Lymphology","volume":"53","author":"of the International Society of Lymphology","year":"2020","journal-title":"J. Biological Chem."},{"issue":"4","key":"10.1016\/j.intimp.2025.115066_b24","doi-asserted-by":"crossref","first-page":"314","DOI":"10.4062\/biomolther.2014.045","article-title":"Pachymic acid enhances pentobarbital-induced sleeping behaviors via GABAA-ergic systems in mice","volume":"22","author":"Shah","year":"2014","journal-title":"Biomol. Ther."},{"key":"10.1016\/j.intimp.2025.115066_b25","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102765","article-title":"EETs alleviate alveolar epithelial cell senescence by inhibiting endoplasmic reticulum stress through the Trim25\/Keap1\/Nrf2 axis","volume":"63","author":"Zhang","year":"2023","journal-title":"Redox Biology"},{"issue":"1","key":"10.1016\/j.intimp.2025.115066_b26","first-page":"11","article-title":"Volume measurement in lymphoedema treatment: examination of formulae","volume":"4","author":"Sitzia","year":"1995","journal-title":"Eur. J. Cancer Care"},{"issue":"7","key":"10.1016\/j.intimp.2025.115066_b27","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1021\/tx900105n","article-title":"Benzylic oxidation of gemfibrozil-1-o-\u03b2-glucuronide by P450 2C8 leads to heme alkylation and irreversible inhibition","volume":"22","author":"Baer","year":"2009","journal-title":"Chem. Res. Toxicol."},{"issue":"7","key":"10.1016\/j.intimp.2025.115066_b28","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1124\/dmd.117.075036","article-title":"LKY-047: first selective inhibitor of cytochrome P450 2j2","volume":"45","author":"Phuc","year":"2017","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.intimp.2025.115066_b29","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.fct.2014.04.020","article-title":"Potential of decursin to inhibit the human cytochrome P450 2J2 isoform","volume":"70","author":"Lee","year":"2014","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.intimp.2025.115066_b30","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/978-1-4939-9133-4_17","article-title":"In vitro spheroid sprouting assay of angiogenesis","author":"Zahra","year":"2019","journal-title":"Extracell. Matrix: Methods Protoc."},{"issue":"7","key":"10.1016\/j.intimp.2025.115066_b31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041126","article-title":"Pathological steps of cancer-related lymphedema: histological changes in the collecting lymphatic vessels after lymphadenectomy","volume":"7","author":"Mihara","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2025.115066_b32","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00441-015-2262-0","article-title":"Soluble epoxide hydrolase inhibitor 1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea attenuates bleomycin-induced pulmonary fibrosis in mice","volume":"363","author":"Zhou","year":"2016","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.intimp.2025.115066_b33","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.3389\/fphar.2018.01222","article-title":"Sexually dimorphic regulation of EET synthesis and metabolism: roles of estrogen","volume":"9","author":"Huang","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115066_b34","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1146\/annurev-physiol-022516-034008","article-title":"Lymphatic dysfunction, leukotrienes, and lymphedema","volume":"80","author":"Jiang","year":"2018","journal-title":"Annu. Rev. Physiol."},{"issue":"12","key":"10.1016\/j.intimp.2025.115066_b35","doi-asserted-by":"crossref","first-page":"6621","DOI":"10.3390\/ijms23126621","article-title":"Current mechanistic understandings of lymphedema and lipedema: tales of fluid, fat, and fibrosis","volume":"23","author":"Duhon","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.intimp.2025.115066_b36","article-title":"Manual lymphatic drainage for lymphedema following breast cancer treatment","author":"Ezzo","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"issue":"10","key":"10.1016\/j.intimp.2025.115066_b37","doi-asserted-by":"crossref","first-page":"H1229","DOI":"10.1152\/ajpheart.00527.2013","article-title":"Fibrosis worsens chronic lymphedema in rodent tissues","volume":"308","author":"Lynch","year":"2015","journal-title":"Am. J. Physiology- Hear. Circ. Physiol."},{"issue":"6","key":"10.1016\/j.intimp.2025.115066_b38","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1007\/s12010-023-04686-5","article-title":"Pachymic acid protects against bleomycin-induced pulmonary fibrosis by suppressing fibrotic, inflammatory, and oxidative stress pathways in mice","volume":"196","author":"Wang","year":"2024","journal-title":"Appl. Biochem. Biotechnol."},{"issue":"5","key":"10.1016\/j.intimp.2025.115066_b39","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/s41401-022-01026-x","article-title":"Poricoic acid a suppresses renal fibroblast activation and interstitial fibrosis in UUO rats via upregulating Sirt3 and promoting \u03b2-catenin K49 deacetylation","volume":"44","author":"Chen","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"issue":"4","key":"10.1016\/j.intimp.2025.115066_b40","doi-asserted-by":"crossref","DOI":"10.3892\/etm.2021.9720","article-title":"Poricoic acid A suppresses TGF-\u03b21-induced renal fibrosis and proliferation via the PDGF-C, Smad3 and MAPK pathways","volume":"21","author":"Li","year":"2021","journal-title":"Exp. Ther. Med."},{"issue":"7","key":"10.1016\/j.intimp.2025.115066_b41","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1194\/jlr.M074229","article-title":"CYP2J2 metabolites, epoxyeicosatrienoic acids, attenuate Ang II-induced cardiac fibrotic response by targeting G\u03b112\/13","volume":"58","author":"He","year":"2017","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.intimp.2025.115066_b42","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1124\/jpet.104.068536","volume":"311","author":"Shitara","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"19","key":"10.1016\/j.intimp.2025.115066_b43","doi-asserted-by":"crossref","first-page":"10714","DOI":"10.3390\/ijms221910714","article-title":"Epoxyeicosatrienoic acids and fibrosis: recent insights for the novel therapeutic strategies","volume":"22","author":"Guan","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2025.115066_b44","doi-asserted-by":"crossref","DOI":"10.1016\/j.phytochem.2024.114343","article-title":"Sesquiterpenoids from inula britannica and their potential mechanism for immunomodulation","volume":"231","author":"Zhang","year":"2025","journal-title":"Phytochemistry"},{"issue":"3","key":"10.1016\/j.intimp.2025.115066_b45","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1021\/acscentsci.2c01424","article-title":"Macrophage inactivation by small molecule wedelolactone via targeting sEH for the treatment of LPS-induced acute lung injury","volume":"9","author":"Zhang","year":"2023","journal-title":"ACS Central Sci."},{"issue":"9","key":"10.1016\/j.intimp.2025.115066_b46","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2118818119","article-title":"Kurarinone alleviated Parkinson\u2019s disease via stabilization of epoxyeicosatrienoic acids in animal model","volume":"119","author":"Sun","year":"2022","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2025.115066_b47","doi-asserted-by":"crossref","first-page":"294","DOI":"10.7150\/ijbs.78097","article-title":"Direct targeting of sEH with alisol B alleviated the apoptosis, inflammation, and oxidative stress in cisplatin-induced acute kidney injury","volume":"19","author":"Zhang","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.intimp.2025.115066_b48","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2023.131890","article-title":"Genetic deletion or pharmacological inhibition of soluble epoxide hydrolase attenuated particulate matter 2.5 exposure mediated lung injury","volume":"458","author":"Zhang","year":"2023","journal-title":"J. Hazard. Mater."},{"key":"10.1016\/j.intimp.2025.115066_b49","article-title":"Discovery of soluble epoxide hydrolase inhibitors from Inula britannica: Inhibition kinetics, molecular dynamics simulation, biochemical, and in vitro cell-based studies","volume":"306","author":"Jia","year":"2025","journal-title":"Int. J. Biiol. Macromol."},{"issue":"2","key":"10.1016\/j.intimp.2025.115066_b50","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0022-2275(20)32049-6","article-title":"Cytochrome P450 and arachidonic acid bioactivation: molecular and functional properties of the arachidonate monooxygenase","volume":"41","author":"Capdevila","year":"2000","journal-title":"J. Lipid Res."},{"issue":"39","key":"10.1016\/j.intimp.2025.115066_b51","doi-asserted-by":"crossref","first-page":"36059","DOI":"10.1074\/jbc.R100030200","article-title":"Epoxygenase pathways of arachidonic acid metabolism","volume":"276","author":"Zeldin","year":"2001","journal-title":"J. Biol. Chem."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925010562?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925010562?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T03:39:27Z","timestamp":1786160367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925010562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":51,"alternative-id":["S1567576925010562"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115066","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pachymic acid alleviates secondary lymphedema through the modulation of EETs level and the inhibition of lymphatic fibrosis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115066"}}